Aprogen Medicines Inc. (KRX:007460)
2,160.00
-55.00 (-2.48%)
Jul 14, 2026, 3:30 PM KST
Aprogen Medicines Market Cap
Aprogen Medicines has a market cap or net worth of 46.6 billion as of July 13, 2026. Its market cap has decreased by -75.29% in one year.
Market Cap
46.60B
Enterprise Value
483.46B
Revenue
127.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,160.00
Market Cap Chart
Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 46.60B, an increase of 138.27%. That is a compound annual growth rate of 2.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 46.60B | -78.33% |
| Dec 30, 2025 | 215.06B | -2.20% |
| Dec 30, 2024 | 219.89B | -6.16% |
| Dec 28, 2023 | 234.32B | -41.38% |
| Dec 27, 2022 | 399.71B | 19.11% |
| Dec 30, 2021 | 335.57B | -10.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KPX Holdings | 339.60B |
| Hyundai Futurenet | 324.29B |
| KG Chemical | 286.41B |
| HS HYOSUNG | 161.78B |
| Woongjin | 150.38B |
| JLK, Inc. | 118.80B |
| Gridwiz | 112.39B |
| HLB GLOBAL | 60.13B |